Evidence map›Paper›PMID 41553378›Full record

ArticleCardiovascular research2026

Fibroblast-like cells accumulate late in human coronary atherosclerosis contributing to necrotic core formation.

Daniel Morales-Cano, Diana Sharysh, Julián Albarrán-Juárez, Antonio de Molina, Verónica Labrador-Cantarero, Cecilie Markvard Møller, Laura Carramolino, Jacob F Bentzon

Abstract read
In one paragraph

Article in Cardiovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Daniel Morales-CanoCentro Nacional de Investigaciones Cardiovasculares (CNIC), Calle Melchor Fernández Almagro, 3, Madrid 28029, Spain.ORCID 0000-0002-1692-4633
Diana SharyshDepartment of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, 8200 Aarhus N, Denmark.ORCID 0000-0003-2173-2772
Julián Albarrán-JuárezDepartment of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, 8200 Aarhus N, Denmark.ORCID 0000-0003-2493-1435
Antonio de MolinaCentro Nacional de Investigaciones Cardiovasculares (CNIC), Calle Melchor Fernández Almagro, 3, Madrid 28029, Spain.ORCID 0000-0002-5603-8492
Verónica Labrador-CantareroCentro Nacional de Investigaciones Cardiovasculares (CNIC), Calle Melchor Fernández Almagro, 3, Madrid 28029, Spain.ORCID 0000-0001-9907-4998
Cecilie Markvard MøllerDepartment of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, 8200 Aarhus N, Denmark.ORCID 0009-0005-1195-7769
Laura CarramolinoCentro Nacional de Investigaciones Cardiovasculares (CNIC), Calle Melchor Fernández Almagro, 3, Madrid 28029, Spain.ORCID 0000-0002-1661-618X
Jacob F BentzonCentro Nacional de Investigaciones Cardiovasculares (CNIC), Calle Melchor Fernández Almagro, 3, Madrid 28029, Spain.ORCID 0000-0002-3020-5002

Funding

Aarhus University Research Foundation AUFF-E-201 9-723European Regional Development Fund IJC2020-044971-IEuropean Regional Development Fund PID2019-108568RB-I00European Research Council 866240Independent Research Fund Denmark 0134-00335BInstituto de Salud Carlos III, the Ministerio de Ciencia e InnovaciónNovo Nordisk Foundation NNF18OC0030688Pro-CNIC FoundationSevero Ochoa Center of Excellence CEX2020-001041-SSevero Ochoa Center of Excellence MICIN/AEI/10.13039/501100011033Spanish Ministerio de Ciencia, Innovación y Universidades
6 · The paper itself

Abstract

aimsProliferation of arterial smooth muscle cells (SMCs) and their modulation to alternative mesenchymal phenotypes is central to atherosclerotic lesion growth. It has been studied extensively in mouse models, but a detailed analysis of when and where different mesenchymal cell types accumulate in human atherosclerosis is lacking. This study mapped mesenchymal cell populations during the progression of human coronary atherosclerosis and explored their associations with disease processes in human carotid plaques. METHODS AND

resultsMultiplex immunostaining protocols based on single-cell RNA sequencing-validated markers were established to detect SMCs, putatively SMC-derived mesenchymal cell subsets expressing osteoprotegerin or lumican, and macrophages in sections of left anterior descending arteries from forensic autopsies. The material comprised 44 arterial segments from 38 individuals, spanning normal intima, adaptive intimal thickening, pathological intimal thickening, and fibroatheroma. Parallel analysis of carotid endarterectomy samples allowed examination of mesenchymal cell involvement in fibrosis, calcification, and apoptosis. Validated machine learning-assisted cell classification was used to phenotype entire plaques at high microscopic resolution. The combined mesenchymal cell population constituted the majority of plaque cells at all plaque stages. Cells co-expressing contractile and mesenchymal cell markers were present in normal human coronary arteries, but mesenchymal cells lacking contractile protein expression became prominent only at the fibroatheroma stage, where fibroblast-like lumican-expressing cells localized preferentially around the necrotic core. The mesenchymal cell subtypes showed no preferential co-localization with areas of fibrosis or calcification; however, secreted osteoprotegerin was found bound to calcium deposits. Fibroblast-like, lumican-expressing cells accounted for 38-54% of all apoptotic cells for which a cell origin could be determined.

conclusionPutative SMC-derived mesenchymal cells without contractile protein expression expand at the fibroatheroma stage of coronary atherosclerosis. Fibroblast-like cells localize around the necrotic core region and account for many apoptotic cells in plaques, suggesting a role in necrotic core development.

Indexed as

Carotid Artery DiseasesCell ProliferationCoronary Artery DiseaseCoronary VesselsFibroblastsMesenchymal Stem CellsMuscle, Smooth, VascularMyocytes, Smooth MusclePlaque, AtheroscleroticAgedApoptosisAutopsyBiomarkersFemaleFibrosisHumansBiomarkersLumicanLUM protein, humanOsteoprotegerinTNFRSF11B protein, humanAtherosclerosisNecrotic corePhenotypic modulationSmooth muscle cells

Identifiers

PMID41553378
PMCPMC13019684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.